Every trade that managers of Livero Inc. disclose to EDINET (Japan FSA) is tracked on this page. Over the twelve months to 19 October 2026, 8 filings were filed, from 5 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (3,419 companies, median 3 filings), a count of 8 filings is above the norm.
No insider has bought Livero Inc. shares on the open market in the past twelve months. Filings reach the EDINET (Japan FSA) feed a median of 6 days after the trade. This delay matters because a trade only becomes useful information once it is public.
These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
13 of 13 declarations
株式会社リベロ is a company listed on the XTKS market. It operates in the financial sector, providing various financial services and products.
Insider filings
Over the last 90 days, 4 filings published between 28 August and 9 October 2026: no open-market purchase or sale filed by an insider. 4 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)